Author:
Eklund Meryle J.,Mody Tejal,Alazraki Adina L.,Siegel Marilyn J.
Publisher
Springer International Publishing
Reference105 articles.
1. Brodeur GM, Maris JM. No title. In: Pizzo P, Poplack D, editors. Principles and practice of pediatric oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 933–70.
2. Lonergan G, Schwab C, Suarez E, Carlson C. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics. 2002;22(4):911–34.
3. Brodeur G, Pritchard J, Berthold F, Carlsen N, Castel V, Castleberry R, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11(8):1466–77.
4. Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE. Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017;17(4):369–86.
5. LaBrosse EH, Comoy E, Bohuon C, Zucker JM, Lemerle J, Schweisguth O, et al. Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors. Cancer Res. 1980;40(6):1995–2001.